COPD Trial, Recruiting NCT06888557 Sponsor: Hong Kong Metropolitan University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06888557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 years or older
  • People who have a confirmed diagnosis of COPD (a chronic lung condition)
  • People who have had a COPD flare-up in the past 6 months that required a hospital stay, medical treatment, or a visit to a doctor
  • People who a doctor and the trial team have assessed as mentally, cognitively, and physically suitable to participate
  • People who can speak and read Chinese
  • People who have completed a standard questionnaire about physical activity readiness (the PAR-Q)
  • People who own a smartphone with WhatsApp or WeChat installed

Who may not be able to join:

  • People who have another significant lung disease, or severe heart failure classified as Class 4 by standard medical guidelines (confirm with trial site)
  • People who currently have a serious active infection
  • People who are unable to walk
  • People who have an unstable psychiatric (mental health) illness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Agnes YK Lai, PhD, Hong Kong Metropolitan University

Phone: (852)3970-2917

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hong Kong Metropolitan University
Registry
ClinicalTrials.gov
Start date
19 March 2025
Est. completion
31 December 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov